Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells